Cellular barcoding helps scientists understand the behavior of stem cells
By tagging bone marrow cells of mice with a genetic label, or barcode, researchers were able to track and describe the family tree of individual blood cells as they form in their natural environment.
Stem cell transplant for severe scleroderma improves survival, quality of life
New clinical trial findings show that a therapeutic regimen involving transplantation of a persons own blood-forming stem cells can improve survival and quality of life for people with severe scleroderma, a life-threatening autoimmune Adisease.
STEMCELL Technologies Brings Groundbreaking Intestinal and Brain Organoid Culture Tools to the Global Research Community
STEMCELL Technologies Inc. has released two product lines for organoid research that will enable scientists to create powerful models for studying human disease in the lab.
U.S. doctors plan to treat cancer patients using CRISPR
the first human test in the U.S. involving the gene-editing tool CRISPR could begin at any time and will employ the DNA cutting technique in a bid to battle deadly cancers.
Gene Editing Needs to Be Available to Everyone
When I was growing up, the idea of re-engineering human DNA was a staple of science fiction. Now, it’s a reality. Adult gene therapy editing the genome of a person is expected to soon be a treatment option for a number of otherwise intractable diseases.
Monkeys cloned in world first, scientists reveal
Two monkeys are the first ever primates to be cloned using the technique that created Dolly the sheep.
In 2018, We Will CRISPR Human Beings
Ever since 2012, when researchers first discovered that bacterial immune systems could be hijacked to edit DNA in living creatures, CRISPR has been hailed as a maker of revolutions.
Phase III clinical trials for stem cell-based cartilage regeneration therapy have started
A group of researchers at Osaka University developed a synthetic tissue using synovium-derived mesenchymal stem cells (MSCs) for treating damaged cartilage, which had previously been incurable and had no effective therapies.
State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.
Jaw bones regeneration using mesenchymal stem cells. A single-center experience.
Mesenchymal stem cells (MSC), which are multipotent stromal cells, are considered to be a promising resource in tissue engineering and tissue regeneration. MSCs have been used to generate new maxillary bone with clinically successful results. The aim of this study was to determine the role of MSC in bone regeneration procedures in patients with benign maxillary lesions.
